Heart Rate Recovery (HRR) is a crucial metric that offers valuable insights into cardiovascular health and fitness. This measure reflects how efficiently the heart returns to its resting rate after intense physical activity. After exertion, a rapid decline in heart rate is indicative of a well-conditioned cardiovascular system, demonstrating the heart's ability to recover swiftly and efficiently. Monitoring HRR provides a glimpse into one's overall cardiovascular fitness and can serve as an essential tool for athletes, fitness enthusiasts, and healthcare professionals alike. Studies have shown that a slower heart rate recovery may be linked to an increased risk of cardiovascular issues, making it a useful parameter for assessing an individual's risk profile. Incorporating HRR assessment into fitness routines allows individuals to tailor their exercise regimens to improve cardiovascular health and enhance overall well-being. As such, understanding and optimizing Heart Rate Recovery can be a valuable component of a holistic approach to maintaining a healthy heart and body.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India